About Us
Empowering Wellness
Brij Strategic Consultations, LLC (Brij Strategic) is a Maryland-based pharmaceutical company specializing in the development of therapeutic and diagnostic products for degenerative diseases. With over two decades of expertise, we focus on advancing treatments for conditions such as dementia, arthritis, inflammatory diseases, frailty, Alzheimer’s disease, Parkinson’s disease, and other related indications. Our mission is to transform groundbreaking scientific discoveries into real-world medical solutions that enhance patient outcomes and improve quality of life.
At Brij Strategic, we bring together a multidisciplinary team of scientists, clinicians, and regulatory experts to drive medical innovation. Our goal is to bridge the gap between promising scientific research and real-world patient applications. We employ cutting-edge technologies, strategic collaborations, and a regulatory-first approach to ensure that novel therapies reach the market efficiently and compliantly.
Years of Experience
0
+
Our Expertise and Core Competencies
- Early-Stage Clinical Product Development
- Regulatory Strategy and Compliance
- Translational Medicine and Technology Development
Why Partner with Brij Strategic Consultations, LLC?
With over 10 years of experience in pharmaceutical development, we have successfully guided numerous therapies from the early R&D stage to clinical trials and regulatory approval. Our expertise in navigating the drug development process ensures that innovative treatments reach patients in the most efficient and compliant manner possible.
From discovery to market approval, we provide end-to-end solutions tailored to the specific needs of each project. Our integrated approach includes preclinical development, clinical trial design, regulatory affairs, and commercialization strategy.
We maintain close relationships with regulatory authorities, contract research organizations (CROs), and clinical trial sites, enabling us to execute trials efficiently and accelerate product approvals.
Brij Strategic is dedicated to fostering innovation in the pharmaceutical and biotechnology sectors. We continuously seek cutting-edge therapies and diagnostic solutions that have the potential to transform patient care.
Our Areas of Focus
Advancing breakthrough therapies in neurodegenerative diseases, inflammatory disorders, and regenerative medicine to address critical unmet medical needs.
Neurodegenerative Diseases
We are committed to developing therapies for neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and dementia. Our research focuses on novel mechanisms to slow disease progression, enhance cognitive function, and improve patient outcomes. (please see the company profile for one of our companies, Vitti Labs, LLC)
Inflammatory and Autoimmune Disorders
Inflammatory diseases and autoimmune conditions represent a significant unmet medical need. We work on innovative treatments targeting inflammation pathways to address conditions such as arthritis, Crohn’s disease, and other chronic inflammatory disorders. (please see the company profile for one of our companies Akan Biosciences, Inc.)
Regenerative Medicine and Cell-Based Therapies
Regenerative medicine is a core area of our expertise. We are actively involved in the development of stem cell-based therapies and tissue engineering approaches to restore function in degenerative diseases. (please see the company profile for one of our companies Akan Biosciences, Inc.)
Our Process
From Innovation to Market
Guiding therapies from discovery to market through expert evaluation, rigorous development, regulatory strategy, and seamless clinical execution.
01
Identification and Evaluation
We actively seek and evaluate promising new technologies in the pharmaceutical and biotechnology space. Our team conducts rigorous scientific and commercial assessments to identify high-potential therapies. We assess market potential, intellectual property, and regulatory feasibility to ensure that selected projects align with both industry needs and scientific innovation.
02
Preclinical Development
Once a technology is identified, we facilitate preclinical research, including laboratory studies, animal models, and proof-of-concept evaluations to validate safety and efficacy. Our preclinical development process is designed to generate the robust data necessary for regulatory submission and clinical trial readiness. We work closely with GLP and GMP-compliant contract research organizations (CROs) to conduct thorough pharmacokinetic, toxicology, and POC efficacy studies
03
Regulatory Strategy and IND Submission
Our regulatory experts design a tailored strategy for each product, ensuring compliance with FDA and global regulatory standards. We prepare and submit Investigational New Drug (IND) applications to initiate clinical trials. Our team provides regulatory consulting and documentation preparation, addressing any regulatory concerns proactively to avoid delays in clinical development.
04
Clinical Trial Execution
Brij Strategic Consultations, LLC manages all phases of clinical trials, from Phase I safety studies to late-stage efficacy trials. We collaborate with clinical research organizations, investigators, and regulatory bodies to ensure seamless execution. Our team oversees site selection, patient recruitment, trial monitoring, and data analysis, ensuring that trials are conducted ethically, efficiently, and in compliance with regulatory requirements.
05
Market Approval and Commercialization
Our team guides therapies through the final stages of regulatory approval and commercialization. We develop go-to-market strategies, secure payer reimbursement pathways, and establish partnerships for product launch. We also provide post-market surveillance and lifecycle management strategies to optimize long-term commercial success.